Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stress and Mental Health01:30

Stress and Mental Health

189
Chronic stress profoundly affects mental health, significantly influencing mood, behavior, and overall quality of life. Research closely links chronic stress with mental health conditions such as depression, anxiety, and substance use disorders. Ongoing exposure to stress can lead to physiological and psychological changes, initiating a cycle of emotional distress and maladaptive coping mechanisms.
Individuals with depression often experience challenges in both their personal and professional...
189
Anxiety: Overview01:18

Anxiety: Overview

318
Anxiety is a common mental disorder featuring excessive worry, fear, and apprehension, significantly affecting daily life. People with anxiety disorders experience persistent and intense anxiety, interrupting their everyday functioning.
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
318
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

148
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
148
Panic Disorder01:27

Panic Disorder

160
Panic disorder is an anxiety disorder characterized by recurrent and sudden minutes-long episodes of intense fear, known as panic attacks. These attacks may feel like heart attacks and often happen without warning or a specific cause. They can include symptoms such as rapid heart rate, shortness of breath, chest pain, trembling, sweating, dizziness, and a sense of helplessness. During a panic attack, individuals may feel as though they are experiencing a heart attack or are in a...
160
Social Anxiety Disorder01:28

Social Anxiety Disorder

67
Social anxiety disorder, also known as social phobia, is characterized by an intense fear of social situations where one might face humiliation, rejection, embarrassment, or negative evaluation. This disorder leads individuals to avoid activities like casual conversations, public speaking, or seemingly simple tasks such as eating, signing documents, or swimming, in public settings. Its impact extends beyond discomfort, often significantly interfering with daily functioning and quality of life.
67
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

182
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
182

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular basis of CXC chemokine receptor 3 ligand multispecificity.

Science advances·2026
Same author

Lymphadenopathy: Evaluation and Differential Diagnosis.

American family physician·2025
Same author

Effects of chemotherapy on skeletal muscle mitochondrial oxidative capacity using near-infrared spectroscopy (NIRS): Protocol paper for an observational mixed model repeated measures design in patients with breast and gynecological cancer.

PloS one·2025
Same author

A Case of Necrotizing Lymphadenitis From Streptococcus pyogenes.

Cureus·2025
Same author

Frontal damage and resolution of schizophrenia in a patient with self-inflicted gunshot wound: a case report.

BMC neurology·2025
Same author

Impact of Time in Therapeutic Range on Adverse Events in Atrial Fibrillation Patients in an Ambulatory Care Setting.

Hospital pharmacy·2024

Related Experiment Video

Updated: Aug 3, 2025

A New Method for Inducing a Depression-Like Behavior in Rats
07:57

A New Method for Inducing a Depression-Like Behavior in Rats

Published on: February 22, 2018

21.0K

Mood and Anxiety Disorders: Suicide.

Ashley Wilk1, Ashley Falk1, Rosa Joseph1

  • 1Department of Family Medicine and Rural Health - Florida State University College of Medicine, 1115 West Call St, Tallahassee, FL 32306.

FP Essentials
|April 10, 2023
PubMed
Summary

Suicide prevention requires understanding risk factors like isolation and mental health conditions. Physicians should directly assess suicide plans, as questioning does not increase risk, and manage comorbid mood disorders.

More Related Videos

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

118
Social Isolation Model: A Noninvasive Rodent Model of Stress and Anxiety
04:20

Social Isolation Model: A Noninvasive Rodent Model of Stress and Anxiety

Published on: November 11, 2022

4.4K

Related Experiment Videos

Last Updated: Aug 3, 2025

A New Method for Inducing a Depression-Like Behavior in Rats
07:57

A New Method for Inducing a Depression-Like Behavior in Rats

Published on: February 22, 2018

21.0K
Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

118
Social Isolation Model: A Noninvasive Rodent Model of Stress and Anxiety
04:20

Social Isolation Model: A Noninvasive Rodent Model of Stress and Anxiety

Published on: November 11, 2022

4.4K

Area of Science:

  • Public Health
  • Psychiatry
  • Clinical Medicine

Background:

  • Suicide caused over 47,500 deaths in the US in 2019.
  • Females attempt suicide more often, but males have higher completed suicide rates.
  • Older adults (over 75) and individuals with mental disorders face elevated suicide risks.

Purpose of the Study:

  • To summarize key aspects of suicide risk, assessment, and management.
  • To highlight pharmacotherapy options for major depressive disorder (MDD) with suicidal ideation.
  • To emphasize the importance of comprehensive suicide risk assessment over "no harm" contracts.

Main Methods:

  • Review of epidemiological data on suicide demographics and risk factors.
  • Discussion of clinical guidelines for suicide risk assessment.
  • Overview of pharmacotherapeutic strategies for managing suicidality, including MDD.

Main Results:

  • Increased suicide risk is associated with isolation, poverty, and mental health conditions like MDD.
  • Direct questioning about suicide plans is safe and essential for risk assessment.
  • Esketamine nasal spray is an approved pharmacotherapy for MDD with acute suicidal ideation/behavior.

Conclusions:

  • Effective suicide prevention involves identifying risk factors and performing thorough clinical evaluations.
  • Pharmacotherapy should target comorbid mood disorders, particularly MDD.
  • Clinical judgment and formal risk assessment are crucial, not solely relying on "no harm" agreements.